# US 2018/0023104 A1 · Materials and methods for directing carbon flux and increased production of carbon based chemicals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023104 A1
- Document ID: US20180023104A1
- Status: Published application
- Kind: A1
- Application number: 15/656,482
- Filed: 2017-07-21
- Published: 2018-01-25
- Earliest claimed: 2016-07-25
- Assignees: Invista North America S.A.R.L.
- Applicants: Invista North America S.A.R.L.
- Inventors: Stephen Cartman; Jonathan Combe; Alexander B. Foster; Jonathan Kennedy
- Web page: https://patentgrep.com/patent/US20180023104A1

## CPC

- C12P 13/005: {Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids}
- C08G 69/08: derived from amino-carboxylic acids
- C08G 69/10: Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)}
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0008: {acting on the aldehyde or oxo group of donors (1.2)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1096: {transferring nitrogenous groups (2.6)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12Y 101/01021: Aldehyde reductase (1.1.1.21), i.e. aldose-reductase
- C12Y 102/01003: Aldehyde dehydrogenase (NAD+) (1.2.1.3)
- C12Y 102/99006: Carboxylate reductase (1.2.99.6)
- C12Y 203/01009: Acetyl-CoA C-acetyltransferase (2.3.1.9)
- C12Y 206/01: Transaminases (2.6.1)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

This disclosure relates to genome-scale attenuation or knockout strategies for directing carbon flux to certain carbon based building blocks within the 7-aminoheptanoic acid (7-AHA) and 6-aminohexanoic acid (6-AHA) biosynthesis pathways, for example, to achieve reduced flux to unwanted side products while achieving increased production of desired intermediates and end products. This disclosure also relates to non-naturally occurring mutant bacterial strains comprising one or more gene disruptions in aldehyde reductase and/or aldehyde dehydrogenase genes that are generated to direct carbon flux to certain carbon based building blocks. This disclosure further relates to a method for enhancing production of carbon based building blocks by generating non-naturally occurring mutant bacterial strains, culturing said mutant bacterial strains in the presence of suitable substrates or under desired growth conditions, and substantially purifying the desired end product.

## Claims

### Claim 1

A method for enhancing biosynthesis of 7-aminoheptanoic acid or 6-aminohexanoic acid comprising:
a) generating a recombinant host comprising one or more gene disruptions in aldehyde reductase and/or aldehyde dehydrogenase genes, wherein said gene disruptions reduce aldehyde reductase and/or aldehyde dehydrogenase activity of polypeptides encoded by said genes, and wherein said recombinant host produces an increased level of 7-aminoheptanoic acid or 6-aminohexanoic acid converted from pimelic acid or pimelic acid derivatives or adipic acid or adipic acid derivatives as compared to a wild-type recombinant host;
b) culturing said recombinant host in the presence of a suitable substrate or metabolic intermediate and under conditions suitable for the conversion of pimelic acid or pimelic acid derivatives to 7-aminoheptanoic acid or adipic acid or adipic acid derivatives to 6-aminohexanoic acid; and
c) obtaining the 7-aminoheptanoic acid or 6-aminohexanoic acid.

### Claim 2 (depends on 1)

The method of claim 1, wherein said pimelic acid derivatives comprise pimelyl-ACP and pimelic acid semialdehyde or said adipic acid derivatives comprise adipoyl-ACP or adipic acid semialdehyde.

### Claim 3 (depends on 1)

The method of claim 1, wherein side products levels other than 7-aminoheptanoic acid converted from pimelic acid or pimelic acid derivatives or 6-aminohexanoic acid converted from adipic acid or adipic acid derivatives are reduced as compared to the wild-type recombinant host.

### Claim 4 (depends on 3)

The method of claim 3, wherein said side products comprise one or more members of the group consisting of 7-hydroxyheptanoic acid, 7-hydroxyheptanal, 1,7-heptanediol, 7-aminoheptanal, 7-aminoheptanol, and 1,7-diaminoheptane or 6-hydroxyhexanoic acid, 6-hydroxyhexanal, 1,6-hexanediol, 6-aminohexanal, 6-aminohexanol, and 1,6-diaminohexane or derivatives thereof.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The method of claim 1, wherein said gene disruptions are achieved through use of a method selected from the group consisting of transposons, homologous recombination, PCR, mutagenesis, enzyme inhibitors, antisense oligonucleotides, nucleic acid interference, RNAi, genome-editing technologies and any combination thereof.

### Claim 7 (depends on 6)

The method of claim 6, wherein said homologous recombination method comprises a double cross-over approach, said PCR method comprises a one-step inactivation approach based on PCR products developed by Datsenko and Wanner or said genome-editing technologies comprise an approach based on CRISPR-Cas9 system or its equivalents.

### Claim at position 8

8-9. (canceled)

### Claim 10 (depends on 1)

The method of claim 1, wherein said recombinant host further comprising at least one polypeptide having the activity of a carboxylic acid reductase classified under EC 1.2.99.- or a polypeptide having the activity of a ω-transaminase (ω-TAM) classified under EC 2.6.1.-.

### Claim 11 (depends on 1)

The method of claim 1, wherein said aldehyde reductase genes encode polypeptides having at least 60% amino acid sequence identity or homology to any one of the polypeptides having the activity of aldehyde reductases classified under EC 1.1.1.- and/or said aldehyde dehydrogenase genes encode polypeptides having at least 60% amino acid sequence identity or homology to any one of the polypeptides having the activity of aldehyde dehydrogenases classified under EC 1.2.1.-.

### Claim at position 11

12-17. (canceled)

### Claim 18 (depends on 1)

The method of claim 1, wherein said aldehyde reductase genes are selected from the group consisting of adhE, yqhD, adhP, eutG, yjgB, yiaY, fucO, betA, eutE, yahK, yqhE, gldA, ybbO, and yghA.

### Claim at position 13

19-25. (canceled)

### Claim 26 (depends on 1)

The method of claim 1, wherein transcription of said aldehyde reductase and/or aldehyde dehydrogenase genes is induced in response to the presence of cognate substrates or is active under a desired growth condition.

### Claim 27 (depends on 26)

The method of claim 26, wherein said cognate substrates comprise at least one of the members of the group consisting of pimelic acid semialdehyde, adipic acid semialdehyde, pimelic acid semialdehyde methyl ester, and adipic acid semialdehyde methyl ester or derivatives thereof.

### Claim 28 (depends on 26)

The method of claim 26, wherein transcriptional induction or activity of said aldehyde reductase and/or aldehyde dehydrogenase genes is identified from gene expression or transcriptomic data.

### Claim at position 17

29-31. (canceled)

### Claim 32 (depends on 26)

The method of claim 26, wherein said desired growth condition comprises glycerol as a carbon source.

### Claim at position 19

33-36. (canceled)

### Claim 37 (depends on 1)

The method of claim 1, wherein the host is:
cultured under aerobic, anaerobic, micro-aerobic or mixed oxygen/denitrification cultivation conditions;
cultured under conditions of nutrient limitation;
retained using a ceramic hollow fiber membrane to maintain a high cell density during fermentation; and/or
fed a principal carbon source derived from biological or non-biological feedstocks.

### Claim at position 21

38-40. (canceled)

### Claim 41 (depends on 37)

The method of claim 37, wherein the biological feedstock is, or derives from, monosaccharides, disaccharides, lignocellulose, hemicellulose, cellulose, lignin, levulinic acid, formic acid, triglycerides, glycerol, fatty acids, agricultural waste, condensed distillers' solubles, or municipal waste or the non-biological feedstock is, or derives from, natural gas, syngas, CO2/H2, CO2, methanol, ethanol, benzoate, non-volatile residue (NVR) caustic wash waste stream from cyclohexane oxidation processes, or terephthalic acid/isophthalic acid mixture waste streams.

### Claim 42

(canceled)

### Claim 43 (depends on 1)

The method of claim 1, wherein the host is a prokaryote from a genus selected from Escherichia, Clostridia, Corynebacteria, Cupriavidus, Pseudomonas, Delftia, Bacillus; Lactobacillus, Lactococcus, or Rhodococcus, or a eukaryote from a genus selected from Aspergillus, Saccharomyces, Pichia, Yarrowia, Issatchenkia, Debaryomyces, Arxula or Kluyveromyces.

### Claim at position 25

44-47. (canceled)

### Claim 48 (depends on 1)

The method of claim 1, wherein the host's tolerance to high concentrations of a C7 or C6 building block or derivative thereof is improved through continuous cultivation in a selective environment.

### Claim 49 (depends on 1)

The method of claim 1, wherein the host comprises:
(i) an alteration of activity of one or more of the following: polyhydroxyalkanoate synthase, an acetyl-CoA thioesterase, an acetyl-CoA specific β-ketothiolase, a phosphotransacetylase forming acetate, an acetate kinase, a lactate dehydrogenase, a menaquinol-fumarate oxidoreductase, a 2-oxoacid decarboxylase producing isobutanol, an alcohol dehydrogenase forming ethanol, a triose phosphate isomerase, a pyruvate decarboxylase, a glucose-6-phosphate isomerase, a transhydrogenase dissipating the NADH or NADPH imbalance, an glutamate dehydrogenase dissipating the NADH or NADPH imbalance, a NADH/NADPH-utilizing glutamate dehydrogenase, a pimeloyl-CoA dehydrogenase; an acyl-CoA dehydrogenase accepting C7 building blocks and central precursors as substrates; a glutaryl-CoA dehydrogenase; or a pimeloyl-CoA synthetase; and/or
(ii) an alteration to overexpress one or more of the following: an acetyl-CoA synthetase, a 6-phosphogluconate dehydrogenase; a transketolase; a puridine nucleotide transhydrogenase; a formate dehydrogenase; a glyceraldehyde-3P-dehydrogenase; a malic enzyme; a glucose-6-phosphate dehydrogenase; a fructose 1,6 diphosphatase; a L-alanine dehydrogenase; a L-glutamate dehydrogenase specific to the NADH or NADPH used to generate a co-factor imbalance; a methanol dehydrogenase, a formaldehyde dehydrogenase, a diamine transporter; a dicarboxylate transporter; an S-adenosylmethionine synthetase and/or a multidrug transporter.

### Claim 50

(canceled)

### Claim 51

A recombinant host comprising one or more gene attenuations in aldehyde reductase and/or aldehyde dehydrogenase genes, wherein said gene attenuations reduce aldehyde reductase and/or aldehyde dehydrogenase activity of polypeptides encoded by said genes, and wherein said recombinant host produces an increased level of 7-aminoheptanoic acid converted from pimelic acid or pimelic acid derivatives or 6-aminohexanoic acid converted from adipic acid or adipic acid derivatives as compared to a wild-type recombinant host.

### Claim 52 (depends on 51)

The recombinant host of claim 51, wherein said pimelic acid derivatives comprise pimelyl-ACP and pimelic acid semialdehyde or said adipic acid derivatives comprise adipoyl-ACP or adipic acid semialdehyde.

### Claim 53 (depends on 52)

The recombinant host of claim 52, wherein side products levels other than 7-aminoheptanoic acid converted from pimelic acid or pimelic acid derivatives or 6-aminohexanoic acid converted from adipic acid or adipic acid derivatives are reduced as compared to the wild-type recombinant host.

### Claim 54 (depends on 53)

The recombinant host of claim 53, wherein said side products comprise one or more members of the group consisting of 7-hydroxyheptanoic acid, 7-hydroxyheptanal, 1,7-heptanediol, 7-aminoheptanal, 7-aminoheptanol, and 1,7-diaminoheptane or 6-hydroxyhexanoic acid, 6-hydroxyhexanal, 1,6-hexanediol, 6-aminohexanal, 6-aminohexanol, and 1,6-diaminohexane, or derivatives thereof.

### Claim 55

(canceled)

### Claim 56 (depends on 51)

The recombinant host of claim 51, wherein said gene attenuations are achieved through use of a method selected from the group consisting of transposons, homologous recombination, PCR, mutagenesis, enzyme inhibitors, antisense oligonucleotides, nucleic acid interference, RNAi, genome-editing technologies, and any combination thereof.

### Claim 57 (depends on 56)

The recombinant host of claim 56, wherein said homologous recombination method comprises double cross-over approach, said PCR method comprises a one-step inactivation approach based on PCR products developed by Datsenko and Wanner or said genome-editing technologies comprise an approach based on CRISPR-Cas9 system or its equivalents.

### Claim at position 36

58-59. (canceled)

### Claim 60 (depends on 51)

The recombinant host of claim 51, further comprising at least one polypeptide having the activity of a carboxylic acid reductase classified under EC 1.2.99.- or a polypeptide having the activity of a ω-transaminase (ω-TAM) classified under EC 2.6.1.-.

### Claim 61 (depends on 51)

The recombinant host of claim 51, wherein said aldehyde reductase genes encode polypeptides having at least 60% amino acid sequence identity or homology to any one of the polypeptides having the activity of aldehyde reductases classified under EC 1.1.1.- and/or said aldehyde dehydrogenase genes encode polypeptides having at least 60% amino acid sequence identity or homology to any one of the polypeptides having the activity of aldehyde dehydrogenases classified under EC 1.2.1.-.

### Claim at position 39

62-67. (canceled)

### Claim 68 (depends on 51)

The recombinant host of claim 51, wherein said aldehyde reductase genes are selected from the group consisting of adhE, yqhD, adhP, eutG, yjgB, yiaY, fucO, betA, eutE, yahK, yqhE, gldA, ybbO, and yghA.

### Claim at position 41

69-75. (canceled)

### Claim 76 (depends on 51)

The recombinant host of claim 51, wherein transcription of said aldehyde reductase and/or aldehyde dehydrogenase genes is induced in response to the presence of cognate substrates or is active under a desired growth condition.

### Claim 77 (depends on 76)

The recombinant host of claim 76, wherein said cognate substrates comprise at least one of the members of the group consisting of pimelic acid semialdehyde, adipic acid semialdehyde, pimelic acid semialdehyde methyl ester, and adipic acid semialdehyde methyl ester or derivatives thereof.

### Claim 78 (depends on 76)

The recombinant host of claim 76, wherein transcriptional induction or activity of said aldehyde reductase and/or aldehyde dehydrogenase genes is identified from gene expression or transcriptomic data.

### Claim at position 45

79-81. (canceled)

### Claim 82 (depends on 76)

The recombinant host of claim 76, wherein said desired growth condition comprises glycerol as a carbon source.

### Claim at position 47

83-84. (canceled)

### Claim 85 (depends on 51)

The recombinant host of claim 51, wherein said aldehyde reductase and/or aldehyde dehydrogenase genes are identified by adding a cognate aldehyde substrate to cell extracts from said recombinant host.

### Claim 86 (depends on 51)

The recombinant host of claim 51, wherein the host is:
cultured under aerobic, anaerobic, micro-aerobic or mixed oxygen/denitrification cultivation conditions;
cultured under conditions of nutrient limitation;
retained using a ceramic hollow fiber membrane to maintain a high cell density during fermentation; and/or
fed a principal carbon source derived from biological or non-biological feedstocks.

### Claim at position 50

87-89. (canceled)

### Claim 90 (depends on 86)

The recombinant host of claim 86, wherein the biological feedstock is, or derives from, monosaccharides, disaccharides, lignocellulose, hemicellulose, cellulose, lignin, levulinic acid, formic acid, triglycerides, glycerol, fatty acids, agricultural waste, condensed distillers' solubles, or municipal waste or the non-biological feedstock is, or derives from, natural gas, syngas, CO2/H2, CO2, methanol, ethanol, benzoate, non-volatile residue (NVR) caustic wash waste stream from cyclohexane oxidation processes, or terephthalic acid/isophthalic acid mixture waste streams.

### Claim 91

(canceled)

### Claim 92 (depends on 51)

The recombinant host of claim 51, wherein the host is a prokaryote from the genus Escherichia, Clostridia, Corynebacteria, Cupriavidus, Pseudomonas, Delftia, Bacillus, Lactobacillus, Lactococcus or Rhodococcus or a eukaryote from the genus Aspergillus, Saccharomyces, Pichia, Yarrowia, Issatchenkia, Debaryomyces, Arxula or Kluyveromyces.

### Claim at position 54

93-96. (canceled)

### Claim 97 (depends on 51)

The recombinant host of claim 51, wherein the host's tolerance to high concentrations of a C7 or C6 building block or derivatives thereof is improved through continuous cultivation in a selective environment.

### Claim 98 (depends on 51)

The recombinant host of claim 51, wherein the host comprises:
(i) an alteration in activity of one or more of the following: polyhydroxyalkanoate synthase, an acetyl-CoA thioesterase, an acetyl-CoA specific β-ketothiolase, a phosphotransacetylase forming acetate, an acetate kinase, a lactate dehydrogenase, a menaquinol-fumarate oxidoreductase, a 2-oxoacid decarboxylase producing isobutanol, an alcohol dehydrogenase forming ethanol, a triose phosphate isomerase, a pyruvate decarboxylase, a glucose-6-phosphate isomerase, a transhydrogenase dissipating the NADH or NADPH imbalance, an glutamate dehydrogenase dissipating the NADH or NADPH imbalance, a NADH/NADPH-utilizing glutamate dehydrogenase, a pimeloyl-CoA dehydrogenase; an acyl-CoA dehydrogenase accepting C7 building blocks and central precursors as substrates; a glutaryl-CoA dehydrogenase; or a pimeloyl-CoA synthetase; and/or
(ii) an alteration to overexpress one or more of the following: an acetyl-CoA synthetase, a 6-phosphogluconate dehydrogenase; a transketolase; a puridine nucleotide transhydrogenase; a formate dehydrogenase; a glyceraldehyde-3P-dehydrogenase; a malic enzyme; a glucose-6-phosphate dehydrogenase; a fructose 1,6 diphosphatase; a L-alanine dehydrogenase; a L-glutamate dehydrogenase specific to the NADH or NADPH used to generate a co-factor imbalance; a methanol dehydrogenase, a formaldehyde dehydrogenase, a diamine transporter; a dicarboxylate transporter; an S-adenosylmethionine synthetase and/or a multidrug transporter.

### Claim 99

(canceled)

### Claim 100

A non-naturally occurring organism comprising at least one exogenous nucleic acid encoding at least one polypeptide having the activity of at least one enzyme depicted in any one of FIGS. 1 to 5 or FIG. 12.

### Claim 101

A nucleic acid construct or expression vector comprising a polynucleotide encoding:
a polypeptide having carboxylate reductase activity, wherein the polynucleotide is operably linked to one or more heterologous control sequences that direct production of the polypeptide and wherein the polypeptide having carboxylate reductase activity is selected from the group consisting of: (a) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 1; (b) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 2; (c) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 3; (d) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 4; (e) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 5; and (f) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 6; and/or
a polynucleotide encoding a polypeptide having ω-transaminase activity, wherein the polynucleotide is operably linked to one or more heterologous control sequences that direct production of the polypeptide and wherein the polypeptide having ω-transaminase activity is selected from the group consisting of: (a) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 7; (b) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 8; (c) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 9; (d) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 10; (e) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 11; and (f) a polypeptide having at least 70% sequence identity or homology to the polypeptide of SEQ ID NO: 12.

### Claim 102

(canceled)

### Claim 103 (depends on 101)

A composition comprising the nucleic acid construct or expression vector of claim 101.

### Claim 104

A non-naturally occurring biochemical network comprising a 5-hydroxypentanoyl-CoA, an exogenous nucleic acid encoding a polypeptide having the activity of a β-ketothiolase classified under EC. 2.3.1, and a 3-oxo-7-hydroxyheptanoyl-CoA.

### Claim 105 (depends on 1)

A bio-derived, bio-based or fermentation-derived product, wherein said product comprises:
i. a composition comprising at least one bio-derived, bio-based or fermentation-derived compound biosynthesized according to claim 1, or any one of FIGS. 1-5 or FIG. 12, or any combination thereof,
ii. a bio-derived, bio-based or fermentation-derived polymer comprising the bio-derived, bio-based or fermentation-derived composition or compound of i., or any combination thereof,
iii. a bio-derived, bio-based or fermentation-derived resin comprising the bio-derived, bio-based or fermentation-derived compound or bio-derived, bio-based or fermentation-derived composition of i. or any combination thereof or the bio-derived, bio-based or fermentation-derived polymer of ii. or any combination thereof,
iv. a molded substance obtained by molding the bio-derived, bio-based or fermentation-derived polymer of ii. or the bio-derived, bio-based or fermentation-derived resin of iii., or any combination thereof,
v. a bio-derived, bio-based or fermentation-derived formulation comprising the bio-derived, bio-based or fermentation-derived composition of i., bio-derived, bio-based or fermentation-derived compound of i., bio-derived, bio-based or fermentation-derived polymer of ii., bio-derived, bio-based or fermentation-derived resin of iii., or bio-derived, bio-based or fermentation-derived molded substance of iv, or any combination thereof, or
vi. a bio-derived, bio-based or fermentation-derived semi-solid or a non-semi-solid stream, comprising the bio-derived, bio-based or fermentation-derived composition of i., bio-derived, bio-based or fermentation-derived compound of i., bio-derived, bio-based or fermentation-derived polymer of ii., bio-derived, bio-based or fermentation-derived resin of iii., bio-derived, bio-based or fermentation-derived formulation of v., or bio-derived, bio-based or fermentation-derived molded substance of iv., or any combination thereof.
